Price Transparency reporting is high stakes for pharmaceutical manufacturers, and the consequences of not keeping pace are growing steeper by the day.
Civil monetary penalties are real, are rising, and are being enforced with surprising speed and severity. In fact, one manufacturer was recently hit with a $900,000 fine from a single state. Others are scrambling to meet complex reporting timelines, navigate outdated portals, and manage multiple price triggers across branded, generic, and biosimilar products.
That’s why RLDatix Life Sciences recently hosted a must-watch webinar: Price Transparency Regulatory Overview: Leveraging Our Price Transparency Reporting Solution.
In this on-demand session, Sarah McClure (VP, Knowledge Management) and Kristin Rademacher (Sr. Analyst, Price Transparency) share critical insights into the latest regulatory updates and break down what it actually takes to stay compliant in 2025 and beyond.
Watch the webinar to learn:
- Which states are cracking down hardest — like California, Maine, and Oregon — and what triggers their reporting requirements
- How to avoid fines of $5,000 to $30,000 per day (yes, per day) for missing or misreporting WAC increases
- Why even generic and biosimilar products are under scrutiny — and how new packaging sizes can trigger “new product” rules
- The growing complexity of multi-state reporting, with conflicting timelines, thresholds, and submission formats
- How RLDatix’s Price Transparency Reporting Solution and Managed Services remove the guesswork, automate compliance, and keep your business protected
“Ensure you have a pricing committee and that your finance, your legal your compliance teams, your executive leadership, your sales commercial are all aware of these reporting requirements” explains Sarah McClure in the webinar, “so that there’s no communication silos and you’re all working cohesively to ensure compliance. Because compliance does not occur in a vacuum.”
With federal requirements potentially on the horizon and more states joining the fray every year, there’s no better time to assess your reporting strategy.
Start by watching the entire on-demand webinar for a detailed walkthrough of what’s changed — and what’s next.
Looking for guidance on reporting compliance?
Don’t miss our upcoming live webinar on April 29 at 2pm ET: “Mastering Price Transparency Reporting – Compliance Best Practices for 2025”. Designed specifically for pharmaceutical manufacturers, this session offers practical strategies to streamline your reporting, reduce compliance risk, and get the most out of the RLDatix Life Sciences Price Transparency Reporting solution.
You’ll walk away with actionable best practices and live solution training to help simplify compliance, even as regulations evolve.
Then, take the next step and download our eBook: Compliant Commercialization 101: Mastering Revenue, Pricing, and Compliance for Emerging Life Sciences Companies. It’s your roadmap to navigating commercialization with confidence.